Rk Capital Management, LLC Jazz Pharmaceuticals PLC Transaction History

Rk Capital Management, LLC

$365 Million
Q2 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$115.19 - $132.77 $2.17 Million - $2.5 Million	18,800 Added 20.43%	110,820 $13.3 Million
Q4 2023 Feb 13, 2024	SELL	$114.26 - $136.0 $5.58 Million - $6.65 Million	-48,875 Reduced 34.69%	92,020 $11.3 Million
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $56,730 - $67,569	-465 Reduced 0.33%	140,895 $18.2 Million
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $795,025 - $955,068	6,490 Added 4.81%	141,360 $17.5 Million
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $761,676 - $912,271	5,685 Added 4.4%	134,870 $19.7 Million
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $1.94 Million - $2.39 Million	14,940 Added 13.08%	129,185 $20.6 Million
Q3 2022 Nov 10, 2022	BUY	$126.59 - $161.18 $758,274 - $965,468	5,990 Added 5.53%	114,245 $15.2 Million
Q2 2022 Aug 12, 2022	BUY	$141.59 - $168.66 $1.14 Million - $1.36 Million	8,050 Added 8.03%	108,255 $16.9 Million
Q1 2022 May 13, 2022	SELL	$129.64 - $160.7 $1.63 Million - $2.02 Million	-12,575 Reduced 11.15%	100,205 $15.6 Million
Q4 2021 Feb 11, 2022	BUY	$119.87 - $145.67 $5.02 Million - $6.1 Million	41,905 Added 59.13%	112,780 $14.4 Million
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $429,657 - $617,198	3,340 Added 4.95%	70,875 $9.23 Million
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $138,573 - $161,253	-865 Reduced 1.26%	67,535 $12 Million
Q1 2021 May 14, 2021	SELL	$150.19 - $173.5 $1.67 Million - $1.93 Million	-11,100 Reduced 13.96%	68,400 $11.2 Million
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $253,278 - $297,090	1,800 Added 2.32%	79,500 $13.1 Million
Q3 2020 Nov 16, 2020	BUY	$105.46 - $144.13 $7.52 Million - $10.3 Million	71,300 Added 1114.06%	77,700 $11.1 Million
Q3 2020 Nov 13, 2020	SELL	$105.46 - $144.13 $8.81 Million - $12 Million	-83,500 Reduced 92.88%	6,400 $1.42 Million
Q2 2020 Aug 13, 2020	BUY	$95.68 - $121.88 $2.06 Million - $2.62 Million	21,500 Added 31.43%	89,900 $9.92 Million
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $412,378 - $717,878	-4,700 Reduced 6.43%	68,400 $6.82 Million
Q4 2019 Feb 13, 2020	SELL	$117.65 - $153.73 $2.47 Million - $3.23 Million	-20,990 Reduced 22.31%	73,100 $10.9 Million
Q3 2019 Nov 13, 2019	BUY	$125.18 - $143.24 $2.26 Million - $2.59 Million	18,090 Added 23.8%	94,090 $12.1 Million
Q2 2019 Aug 13, 2019	BUY	$125.55 - $144.48 $954,180 - $1.1 Million	7,600 Added 11.11%	76,000 $10.8 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $3.57 Million - $4.19 Million	29,300 Added 74.94%	68,400 $9.78 Million
Q4 2018 Feb 13, 2019	SELL	$115.94 - $166.74 $4.73 Million - $6.8 Million	-40,800 Reduced 51.06%	39,100 $4.85 Million
Q3 2018 Nov 13, 2018	BUY	$161.01 - $180.57 $1.5 Million - $1.68 Million	9,300 Added 13.17%	79,900 $13.4 Million
Q2 2018 Aug 13, 2018	SELL	$146.33 - $183.18 $5.02 Million - $6.28 Million	-34,300 Reduced 32.7%	70,600 $12.2 Million
Q1 2018 May 14, 2018	BUY	$135.59 - $157.16 $7.99 Million - $9.26 Million	58,900 Added 128.04%	104,900 $15.8 Million
Q4 2017 Feb 13, 2018	BUY	$131.06 - $150.39 $167,232 - $191,897	1,276 Added 2.85%	46,000 $6.19 Million
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $6.38 Million - $6.96 Million	44,724	44,724 $6.54 Million

Others Institutions Holding JAZZ

# of Institutions

490

Shares Held

57M

Call Options Held

155K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.88B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rk Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rk Capital Management, LLC with notifications on news.

Account